Expression and function of lysophosphatidic acid LPA1 receptor in prostate cancer cells

Rishu Guo, Elizabeth A. Kasbohm, Puneeta Arora, Christopher J. Sample, Babak Baban, Neetu Sud, Perumal Sivashanmugam, Nader H. Moniri, Yehia Daaka

Research output: Contribution to journalArticle

54 Citations (Scopus)

Abstract

The bioactive phospholipid lysophosphatidic acid (LPA) promotes cell proliferation, survival, and migration by acting on cognate G protein-coupled receptors named LPA1, LPA2, and LPA3. We profiled gene expression of LPA receptors in androgen-dependent and androgen-insensitive prostate cancer cells and found that LPA1 gene is differentially expressed in androgen-insensitive and LPA-responsive but not androgen-dependent and LPA-resistant cells. In human prostate specimens, expression of LPA1 gene was significantly higher in the cancer compared with the benign tissues. The androgen-dependent LNCaP cells do not express LPA1 and do not proliferate in response to LPA stimulation, implying LPA1 transduces cell growth signals. Accordingly, stable expression of LPA1 in LNCaP cells rendered them responsive to LPA-induced cell proliferation and decreased their doubling time in serum. Implantation of LNCaP-LPA1 cells resulted in increased rate of tumor growth in animals compared with those tumors that developed from the wild-type cells. Growth of LNCaP cells depends on androgen receptor activation, and we show that LPA1 transduces Gαi-dependent signals to promote nuclear localization of androgen receptor and cell proliferation. In addition, treatment with bicalutamide inhibited LPA-induced cell cycle progression and proliferation of LNCaP-LPA1 cells. These results suggest the possible utility of LPA1 as a drug target to interfere with progression of prostate cancer.

Original languageEnglish (US)
Pages (from-to)4883-4892
Number of pages10
JournalEndocrinology
Volume147
Issue number10
DOIs
StatePublished - Sep 22 2006

Fingerprint

Lysophosphatidic Acid Receptors
Prostatic Neoplasms
Androgens
Cell Proliferation
Androgen Receptors
Growth
Gene Expression
Neoplasms
G-Protein-Coupled Receptors
Cell Movement
lysophosphatidic acid
Prostate
Phospholipids
Cell Survival
Cell Cycle

ASJC Scopus subject areas

  • Endocrinology

Cite this

Guo, R., Kasbohm, E. A., Arora, P., Sample, C. J., Baban, B., Sud, N., ... Daaka, Y. (2006). Expression and function of lysophosphatidic acid LPA1 receptor in prostate cancer cells. Endocrinology, 147(10), 4883-4892. https://doi.org/10.1210/en.2005-1635

Expression and function of lysophosphatidic acid LPA1 receptor in prostate cancer cells. / Guo, Rishu; Kasbohm, Elizabeth A.; Arora, Puneeta; Sample, Christopher J.; Baban, Babak; Sud, Neetu; Sivashanmugam, Perumal; Moniri, Nader H.; Daaka, Yehia.

In: Endocrinology, Vol. 147, No. 10, 22.09.2006, p. 4883-4892.

Research output: Contribution to journalArticle

Guo, R, Kasbohm, EA, Arora, P, Sample, CJ, Baban, B, Sud, N, Sivashanmugam, P, Moniri, NH & Daaka, Y 2006, 'Expression and function of lysophosphatidic acid LPA1 receptor in prostate cancer cells', Endocrinology, vol. 147, no. 10, pp. 4883-4892. https://doi.org/10.1210/en.2005-1635
Guo, Rishu ; Kasbohm, Elizabeth A. ; Arora, Puneeta ; Sample, Christopher J. ; Baban, Babak ; Sud, Neetu ; Sivashanmugam, Perumal ; Moniri, Nader H. ; Daaka, Yehia. / Expression and function of lysophosphatidic acid LPA1 receptor in prostate cancer cells. In: Endocrinology. 2006 ; Vol. 147, No. 10. pp. 4883-4892.
@article{bd0a9d16a1f34542b99ae80fb10a51d4,
title = "Expression and function of lysophosphatidic acid LPA1 receptor in prostate cancer cells",
abstract = "The bioactive phospholipid lysophosphatidic acid (LPA) promotes cell proliferation, survival, and migration by acting on cognate G protein-coupled receptors named LPA1, LPA2, and LPA3. We profiled gene expression of LPA receptors in androgen-dependent and androgen-insensitive prostate cancer cells and found that LPA1 gene is differentially expressed in androgen-insensitive and LPA-responsive but not androgen-dependent and LPA-resistant cells. In human prostate specimens, expression of LPA1 gene was significantly higher in the cancer compared with the benign tissues. The androgen-dependent LNCaP cells do not express LPA1 and do not proliferate in response to LPA stimulation, implying LPA1 transduces cell growth signals. Accordingly, stable expression of LPA1 in LNCaP cells rendered them responsive to LPA-induced cell proliferation and decreased their doubling time in serum. Implantation of LNCaP-LPA1 cells resulted in increased rate of tumor growth in animals compared with those tumors that developed from the wild-type cells. Growth of LNCaP cells depends on androgen receptor activation, and we show that LPA1 transduces Gαi-dependent signals to promote nuclear localization of androgen receptor and cell proliferation. In addition, treatment with bicalutamide inhibited LPA-induced cell cycle progression and proliferation of LNCaP-LPA1 cells. These results suggest the possible utility of LPA1 as a drug target to interfere with progression of prostate cancer.",
author = "Rishu Guo and Kasbohm, {Elizabeth A.} and Puneeta Arora and Sample, {Christopher J.} and Babak Baban and Neetu Sud and Perumal Sivashanmugam and Moniri, {Nader H.} and Yehia Daaka",
year = "2006",
month = "9",
day = "22",
doi = "10.1210/en.2005-1635",
language = "English (US)",
volume = "147",
pages = "4883--4892",
journal = "Endocrinology",
issn = "0013-7227",
publisher = "The Endocrine Society",
number = "10",

}

TY - JOUR

T1 - Expression and function of lysophosphatidic acid LPA1 receptor in prostate cancer cells

AU - Guo, Rishu

AU - Kasbohm, Elizabeth A.

AU - Arora, Puneeta

AU - Sample, Christopher J.

AU - Baban, Babak

AU - Sud, Neetu

AU - Sivashanmugam, Perumal

AU - Moniri, Nader H.

AU - Daaka, Yehia

PY - 2006/9/22

Y1 - 2006/9/22

N2 - The bioactive phospholipid lysophosphatidic acid (LPA) promotes cell proliferation, survival, and migration by acting on cognate G protein-coupled receptors named LPA1, LPA2, and LPA3. We profiled gene expression of LPA receptors in androgen-dependent and androgen-insensitive prostate cancer cells and found that LPA1 gene is differentially expressed in androgen-insensitive and LPA-responsive but not androgen-dependent and LPA-resistant cells. In human prostate specimens, expression of LPA1 gene was significantly higher in the cancer compared with the benign tissues. The androgen-dependent LNCaP cells do not express LPA1 and do not proliferate in response to LPA stimulation, implying LPA1 transduces cell growth signals. Accordingly, stable expression of LPA1 in LNCaP cells rendered them responsive to LPA-induced cell proliferation and decreased their doubling time in serum. Implantation of LNCaP-LPA1 cells resulted in increased rate of tumor growth in animals compared with those tumors that developed from the wild-type cells. Growth of LNCaP cells depends on androgen receptor activation, and we show that LPA1 transduces Gαi-dependent signals to promote nuclear localization of androgen receptor and cell proliferation. In addition, treatment with bicalutamide inhibited LPA-induced cell cycle progression and proliferation of LNCaP-LPA1 cells. These results suggest the possible utility of LPA1 as a drug target to interfere with progression of prostate cancer.

AB - The bioactive phospholipid lysophosphatidic acid (LPA) promotes cell proliferation, survival, and migration by acting on cognate G protein-coupled receptors named LPA1, LPA2, and LPA3. We profiled gene expression of LPA receptors in androgen-dependent and androgen-insensitive prostate cancer cells and found that LPA1 gene is differentially expressed in androgen-insensitive and LPA-responsive but not androgen-dependent and LPA-resistant cells. In human prostate specimens, expression of LPA1 gene was significantly higher in the cancer compared with the benign tissues. The androgen-dependent LNCaP cells do not express LPA1 and do not proliferate in response to LPA stimulation, implying LPA1 transduces cell growth signals. Accordingly, stable expression of LPA1 in LNCaP cells rendered them responsive to LPA-induced cell proliferation and decreased their doubling time in serum. Implantation of LNCaP-LPA1 cells resulted in increased rate of tumor growth in animals compared with those tumors that developed from the wild-type cells. Growth of LNCaP cells depends on androgen receptor activation, and we show that LPA1 transduces Gαi-dependent signals to promote nuclear localization of androgen receptor and cell proliferation. In addition, treatment with bicalutamide inhibited LPA-induced cell cycle progression and proliferation of LNCaP-LPA1 cells. These results suggest the possible utility of LPA1 as a drug target to interfere with progression of prostate cancer.

UR - http://www.scopus.com/inward/record.url?scp=33748747873&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33748747873&partnerID=8YFLogxK

U2 - 10.1210/en.2005-1635

DO - 10.1210/en.2005-1635

M3 - Article

C2 - 16809448

AN - SCOPUS:33748747873

VL - 147

SP - 4883

EP - 4892

JO - Endocrinology

JF - Endocrinology

SN - 0013-7227

IS - 10

ER -